GlassScriptPhysician profile
Edward Joseph Nemet
NPI 1942230115
$225.13
in general payments reported to CMS, 2019-2025
8 companies · $63.29 in 2025
The $63.29 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $51.29 · 2020: $26.33 · 2022: $17.85 · 2023: $13.44 · 2024: $52.93 · 2025: $63.29.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $130.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $129.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $83.72 | 2024-2025 | Krystexxa |
| Ani Pharmaceuticals, INC. | $32.50 | 2025 | Purified Cortrophin Gel |
| Melinta Therapeutics, LLC | $24.88 | 2019 | |
| Horizon Therapeutics Plc | $24.54 | 2019-2023 | Krystexxa |
| Orthofix Medical, INC. | $17.85 | 2022 | |
| Novum Pharma, LLC | $15.31 | 2019 | |
| Bioventus LLC | $13.35 | 2020 | |
| Paratek Pharmaceuticals, INC. | $12.98 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Nemet listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.